Showing results (111-120 of 6,269) with videos related to

Sort By:
Pageof 627
Diabetes, Obesity & Metabolism|August 5, 2017
Efficacy and pharmacokinetics of subcutaneous exendin (9-39) in patients with post-bariatric hypoglycaemiaColleen M Craig, Li-Fen Liu, Thi Nguyen, et al.
Diabetes, Obesity & Metabolism|September 1, 2017
Metformin extended-release versus immediate-release: An international, randomized, double-blind, head-to-head trial in pharmacotherapy-naïve patients with type 2 diabetesNaresh Aggarwal, Anuj Singla, Chantal Mathieu, et al.
Diabetes, Obesity & Metabolism|September 2, 2017
Initiating therapy in patients newly diagnosed with type 2 diabetes: Combination therapy vs a stepwise approachEugenio Cersosimo, Eric L Johnson, Christina Chovanes, et al.
Diabetes, Obesity & Metabolism|September 2, 2017
Better glycaemic control and less hypoglycaemia with insulin glargine 300 U/mL vs glargine 100 U/mL: 1-year patient-level meta-analysis of the EDITION clinical studies in people with type 2 diabetesRobert Ritzel, Ronan Roussel, Andrea Giaccari, et al.
Diabetes, Obesity & Metabolism|July 9, 2016
Glucocorticoid-induced hyperglycaemia in respiratory disease: a systematic review and meta-analysisS Breakey, S J Sharp, A I Adler, et al.
Diabetes, Obesity & Metabolism|July 10, 2016
Similar HbA1c reduction and hypoglycaemia with variable- vs fixed-time dosing of basal insulin peglispro in type 1 diabetes: IMAGINE 7 studyS Garg, J-L Selam, A Bhargava, et al.
Diabetes, Obesity & Metabolism|July 20, 2017
Development of a cardiovascular diseases risk prediction model and tools for Chinese patients with type 2 diabetes mellitus: A population-based retrospective cohort studyEric Yuk Fai Wan, Daniel Yee Tak Fong, Colman Siu Cheung Fung, et al.
Diabetes, Obesity & Metabolism|June 15, 2016
Comparison of the exposure-response relationship of dapagliflozin in adult and paediatric patients with type 2 diabetes mellitusJ Parkinson, W Tang, C-C Johansson, et al.
Diabetes, Obesity & Metabolism|June 15, 2016
Feedback suppression of meal-induced glucagon-like peptide-1 (GLP-1) secretion mediated through elevations in intact GLP-1 caused by dipeptidyl peptidase-4 inhibition: a randomized, prospective comparison of sitagliptin and vildagliptin treatmentOleg Baranov, Melanie Kahle, Carolyn F Deacon, et al.
Diabetes, Obesity & Metabolism|September 8, 2017
Signals in the pancreatic islet microenvironment influence β-cell proliferationKristie I Aamodt, Alvin C Powers
Pageof 627